LOS ANGELES, Nov. 07, 2019 (GLOBE NEWSWIRE) -- The global electronic health record market value is expected to surpass over US$ 30 Bn by 2026 and is anticipated to grow at a CAGR of over 5.5% in terms of revenue during the forecast period from 2019 to 2026 …
WiseGuyReports have announced the addition of a new report titled “2019 Global and Regional 3G/4G Devices Market Research Report Forecast 2025”. PUNE, MAHARASHTRA, INDIA, November 7, 2019 /EINPresswire.com/ -- Report Overview: This report …
Dublin, Nov. 07, 2019 (GLOBE NEWSWIRE) -- The "Arthroscopy Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering. Where is the largest and fastest growing market for the arthroscopy …
Wiseguyreports.Com Publish Market Report On-“Ethylene glycol ethers Market 2019 Global Key Manufacturers Analysis, Sales, Supply, Demand and Forecast to 2025” PUNE, INDIA, November 7, 2019 /EINPresswire.com/ -- Ethylene glycol ethers Market 2019 …
WiseGuyReports.Com Publish a New Market Research Report On –“ Eggshell Membrane Powder Market 2019 – Global Sales,Price,Revenue,Gross Margin and Market Share”. PUNE, INDIA, November 7, 2019 /EINPresswire.com/ -- Eggshell Membrane Powder Market 2019 …
Dublin, Nov. 07, 2019 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics And COPD Drugs Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering. Where is the largest and fastest growing market for the anti-asthmatics and …
WiseGuyReports have announced the addition of a new report titled “2019 Global and Regional Enterprise SSD Controller Market Research Report Forecast 2025”. PUNE, MAHARASHTRA, INDIA, November 7, 2019 /EINPresswire.com/ -- Report Overview: …
WiseGuyReports.Com Publish a New Market Research Report On –“ Digital Pills Market 2019 Global Share,Trend,Segmentation and Forecast to 2024”. PUNE, INDIA, November 7, 2019 /EINPresswire.com/ -- Digital Pills Market 2019 Description: - The …
OMAHA, NEBRASKA, USA, November 7, 2019 /EINPresswire.com/ -- The Nebraska Mesothelioma Victims Center has endorsed the law firm of Karst von Oiste to ensure a Navy Veteran with mesothelioma in Nebraska receives the very best possible financial …
P&V Enterprises goal is to help our clients suceed. NEW YORK, NY, UNITED STATES, November 7, 2019 /EINPresswire.com/ -- P&V Enterprises, a New York City based event and meeting production and management firm is announcing that it also offers …
JACKSONVILLE, Fla., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Stein Mart, Inc. (NASDAQ: SMRT) plans to release its third quarter financial results after the U.S. financial markets close on Wednesday, November 20, 2019. Management will also host a conference call …
LEXINGTON, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will be highlighting its portfolio and …
CINCINNATI, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2019. Fourth Quarter 2019 Highlights (Comparison to Fourth Quarter Fiscal …
– Reached an agreement to be acquired by Alexion; transaction expected to close in first half of 2020 – – Danicopan (ACH-4471) received Breakthrough Therapy designation for treatment of PNH; Phase 2 combination trial top-line results to be presented at …
ANN ARBOR, Mich., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR), today announced that the company will participate in fireside chats at the following conferences: Credit Suisse 28th Annual Healthcare Conference in Phoenix on Tuesday, November 12 …
Fiscal 2020 first quarter revenues of $161.0 million Fiscal 2020 first quarter operating income of $68.3 million Fiscal 2020 first quarter adjusted operating income of $74.7 million NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- MSG Networks Inc. (NYSE: MSGN) …
Announced positive interim results from its ongoing Phase 2a clinical trial evaluating the combination of ALRN-6924 and Pfizer’s IBRANCE® (palbociclib) for the treatment of patients with tumors harboring wild-type p53 and MDM2 amplification or MDM2/CDK4 co …
~ KEVEYIS® (dichlorphenamide) Achieved $5.7 Million in Revenue Along with a Positive Contribution Margin in Third Quarter of 2019; Strongbridge Remains On-Track to Meet or Exceed the Top End of Full-Year KEVEYIS Revenue Guidance of $18 Million to $20 …
SAN DIEGO and TORONTO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the …
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, …
01 days 21:24:09
